OVGP1 and Miyoshi myopathy: Similarly, OVGP1 protein levels were significantly greater in the irinotecan-treated cells than in the control cells (p < 0.05), indicating that pregnanolone and irinotecan could increase ORM1 and OVGP1 expression, thereby suppressing MM growth (Figure 7G,H).